SCB-2020S

N/A

Report date: 2022/08/25 13:34:49

Base Information

Drug NameSCB-2020S
Drug Alias NameSCB-2020S
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionImmunostimulantsCoronavirus spike glycoprotein inhibitors
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Africa
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesClover Biopharmaceuticals Aus Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesClover Pharmaceuticals CorpClover Biopharmaceuticals Aus Pty Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A